Loading...
2934 logo

J Frontier Co.,Ltd.TSE:2934 Stock Report

Market Cap JP¥8.7b
Share Price
n/a
1Y-13.4%
7D4.7%
1D-2.0%
Portfolio Value
View

J Frontier Co.,Ltd.

TSE:2934 Stock Report

Market Cap: JP¥8.7b

J FrontierLtd (2934) Stock Overview

Engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. More details

2934 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends0/6

2934 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW491,113 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
491,113 investors already sharing narratives

J Frontier Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for J FrontierLtd
Historical stock prices
Current Share PriceJP¥1,640.00
52 Week HighJP¥2,050.00
52 Week LowJP¥1,196.00
Beta0.65
1 Month Change13.89%
3 Month Change4.93%
1 Year Change-13.36%
3 Year Change-48.67%
5 Year Changen/a
Change since IPO-50.60%

Recent News & Updates

Analysis Article Jan 22

We Think J FrontierLtd (TSE:2934) Can Stay On Top Of Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Recent updates

Analysis Article Jan 22

We Think J FrontierLtd (TSE:2934) Can Stay On Top Of Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Dec 04

Positive Sentiment Still Eludes J Frontier Co.,Ltd. (TSE:2934) Following 26% Share Price Slump

The J Frontier Co.,Ltd. ( TSE:2934 ) share price has fared very poorly over the last month, falling by a substantial...
Analysis Article Aug 25

Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Jul 29

Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Mar 19

Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Shareholder Returns

2934JP HealthcareJP Market
7D4.7%1.0%-0.9%
1Y-13.4%5.1%42.9%

Return vs Industry: 2934 underperformed the JP Healthcare industry which returned 5.1% over the past year.

Return vs Market: 2934 underperformed the JP Market which returned 42.9% over the past year.

Price Volatility

Is 2934's price volatile compared to industry and market?
2934 volatility
2934 Average Weekly Movement6.0%
Healthcare Industry Average Movement3.7%
Market Average Movement4.2%
10% most volatile stocks in JP Market9.3%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 2934 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 2934's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008202Atsuhiro Nakamurajfrontier.jp

J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. The company operates SOKUYAKU, a platform for online medical treatment, online medication guidance, home delivery of prescription drugs, and digital transformation support for medical institutions.

J Frontier Co.,Ltd. Fundamentals Summary

How do J FrontierLtd's earnings and revenue compare to its market cap?
2934 fundamental statistics
Market capJP¥8.75b
Earnings (TTM)JP¥50.00m
Revenue (TTM)JP¥21.54b
174.9x
P/E Ratio
0.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2934 income statement (TTM)
RevenueJP¥21.54b
Cost of RevenueJP¥12.64b
Gross ProfitJP¥8.90b
Other ExpensesJP¥8.85b
EarningsJP¥50.00m

Last Reported Earnings

Feb 28, 2026

Next Earnings Date

Jul 15, 2026

Earnings per share (EPS)9.37
Gross Margin41.31%
Net Profit Margin0.23%
Debt/Equity Ratio237.5%

How did 2934 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/11 02:57
End of Day Share Price 2026/07/10 00:00
Earnings2026/02/28
Annual Earnings2025/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

J Frontier Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Keita FujinoThe Stock Research Center